ArticleInternational journal of hematology2024

Japanese phase Ib study of the oral PI3K-δ and -γ inhibitor duvelisib in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.

Shinichi Makita et al.PubMed ↗Publisher ↗

No numbers read from the abstract.